Literature DB >> 6181284

The frequency of kidney and urinary tract diseases in a defined population.

R A Hiatt, G D Friedman.   

Abstract

The frequencies of kidney and urinary tract diseases (KUTD) in a defined population are presented. Rates of first hospitalizations with KUTD in the 5-year period, 1971 through 1975, were determined among over 1 million members of the Kaiser Foundation Health Plan (KFHP) of Northern California. Cases were identified from computer-stored ICDA-coded final discharge diagnoses for hospitalizations. Kidney and other urinary tract diseases were final diagnoses in 35.7 first hospitalizations per 10,000 members per year in the period 1971 through 1975. Disease-specific rates were highest for urinary tract infections, benign prostatic hypertrophy, and renal and ureteral calculi. The frequency of KUTD in this population is compared to available rates from other sources.

Entities:  

Mesh:

Year:  1982        PMID: 6181284     DOI: 10.1038/ki.1982.133

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: A case-control study nested within two prospective cohorts.

Authors:  Nicole M Niehoff; Emily C Zabor; Jaya Satagopan; Anders Widell; Thomas R O'Brien; Mingdong Zhang; Nathaniel Rothman; Tom K Grimsrud; Stephen K Van Den Eeden; Lawrence S Engel
Journal:  Environ Res       Date:  2020-05-20       Impact factor: 6.498

3.  Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.

Authors:  Carla G Monico; Adam Weinstein; Zhirong Jiang; Audrey L Rohlinger; Andrea G Cogal; Beth B Bjornson; Julie B Olson; Eric J Bergstralh; Dawn S Milliner; Peter S Aronson
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

4.  Cigarette smoking and the risk of Barrett's esophagus.

Authors:  Ai Kubo; T R Levin; Gladys Block; Gregory Rumore; Charles P Quesenberry; Patricia Buffler; Douglas A Corley
Journal:  Cancer Causes Control       Date:  2008-10-14       Impact factor: 2.506

5.  Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case-control study nested within two prospective cohorts.

Authors:  Lawrence S Engel; Emily C Zabor; Jaya Satagopan; Anders Widell; Nathaniel Rothman; Thomas R O'Brien; Mingdong Zhang; Stephen K Van Den Eeden; Tom K Grimsrud
Journal:  Int J Cancer       Date:  2019-02-14       Impact factor: 7.396

6.  Seroprevalence of HIV-type 1 in a northern California health plan population: an unlinked survey.

Authors:  R A Hiatt; F J Capell; M S Ascher
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

7.  Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus.

Authors:  Ai Kubo; Gladys Block; Charles P Quesenberry; Patricia Buffler; Douglas A Corley
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

8.  Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study.

Authors:  Maryam M Asgari; Jimmy T Efird; E Margaret Warton; Gary D Friedman
Journal:  Int J Environ Res Public Health       Date:  2010-02-03       Impact factor: 3.390

9.  Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.

Authors:  J D Ordonez; R A Hiatt; C P Quesenberry
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

10.  Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA).

Authors:  R A Hiatt; K Tolan; C P Quesenberry
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.